title: Finding the optimal therapeutic window for tacrolimus.
authors.affiliation: Department of Pediatrics, Schulich School of Medicine & Dentistry, London, ON, Canada, N6A 5W9; Department of Pathology and Laboratory Medicine, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada, N5A 5A5; Department of Medicine, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada, N5A 5A5. guido.filler@lhsc.on.ca.
authors.forename: Guido
authors.initials: G
authors.lastname: Filler
mesh_terms: D016903:Drug Monitoring; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood*; D016030:Kidney Transplantation; D008297:Male; D016559:Tacrolimus / Q000097:blood*
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus